Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Dose Iloprost in Systemic Sclerosis
NCT00622687Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Sep 1997
- Primary completion
- Dec 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of iloprost in systemic sclerosis (SSc), sponsored by Charité – Universitätsmedizin Berlin. Started Sep 1997; status: terminated.
02
Drugs
iloprost
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00622687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622687.